Rohto Pharmaceutical Co., Ltd. (4527) Press Release
Notice Regarding the Status of Repurchase of Shares and Completion of Repurchase
Earlier from Rohto Pharmaceutical
- Ono Pharma Enters into a Drug Discovery Partnership with Aitia in Neurological Diseases
- Notice Regarding the Status of Repurchase of Shares
- Rohto Pharmaceutical: Notice Regarding Voluntary Recall of Vietnamese-Made Eye Drops in the United States
- Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2027 (Three Months Ended June 30, 2026)